Highlights
• Skin organoids and skin-on-a-chip technologies provide innovative platforms that closely replicate the structural and functional characteristics of native human skin.
• Integration of bioprinting, microfluidics, and stem cell engineering significantly improves the physiological relevance of artificial skin models.
• Organoids-on-chips, which combine organoids with microfluidic systems, enable precise control of the cellular microenvironment and enhance model complexity and translational potential.
• Despite ongoing challenges in standardization, vascularization, immune integration, and large-scale production, advances in biomaterials and bioengineering continue to drive progress toward clinical and industrial applications.
京公网安备11010802044758号
Comments on this article